galactosyl-(1-3)galactose has been researched along with Peritonitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domenech, N; Fontán, MP; García-Falcón, T; Máñez, R; Martínez, V; Peteiro, J; Rodríguez-Carmona, A | 1 |
1 other study(ies) available for galactosyl-(1-3)galactose and Peritonitis
| Article | Year |
|---|---|
Serum levels of anti-alphaGalactosyl antibodies predict survival and peritoneal dialysis-related enteric peritonitis rates in patients undergoing renal replacement therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antibodies; Antibodies, Heterophile; Ascitic Fluid; Chi-Square Distribution; Child; Disaccharides; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Renal Replacement Therapy; Swine; Tumor Necrosis Factor-alpha | 2006 |